BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 16129128)

  • 21. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages.
    Ross KS; Guess HA; Carter HB
    Urology; 2005 Nov; 66(5):1038-42. PubMed ID: 16286120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing risks and benefits of colorectal cancer screening in elderly patients.
    Ko CW; Sonnenberg A
    Gastroenterology; 2005 Oct; 129(4):1163-70. PubMed ID: 16230070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective.
    Kobayashi T; Goto R; Ito K; Mitsumori K
    Eur J Surg Oncol; 2007 Aug; 33(6):783-9. PubMed ID: 17408910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Life expectancy and the value of early detection.
    Howard DH
    J Health Econ; 2005 Sep; 24(5):891-906. PubMed ID: 16129128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diminishing returns? The costs and benefits of improving health.
    Murphy K; Topel R
    Perspect Biol Med; 2003; 46(3 Suppl):S108-28. PubMed ID: 14563078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early breast cancer detection.
    Foti E; Mancuso S
    Minerva Ginecol; 2005 Jun; 57(3):269-92. PubMed ID: 16166936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cost-effectiveness of prostatic cancer screening].
    Nakagawa S
    Nihon Rinsho; 2000 Jul; 58 Suppl():374-6. PubMed ID: 11022752
    [No Abstract]   [Full Text] [Related]  

  • 29. Localised prostatic cancer: management and detection issues.
    Whitmore WF
    Lancet; 1994 May; 343(8908):1263-7. PubMed ID: 7910280
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.